Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05509959 · ClinicalTrials.gov registry record · NA

Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement

A NA study of HIV/AIDS, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT05509959 is a NA study of HIV/AIDS that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 360 participants, below the 33,175-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05509959, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

A two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed ART but are non-adherent (\< 90% ART adherent in the last 4 weeks) will be enrolled in the study. WLHA will be randomized (1:1) into one of the following conditions: 1) Women SHINE intervention arm (n=180) or 2) Control arm (n=180). The Women SHINE intervention arm will receive a four-month intervention including peer navigator (PN) one-on-one sessions, phone/text-based check-ins, 7 psychoeducation weekly support group sessions (120 mins.) co-facilitated by a licensed therapist and PN, and access to a static website with resources for HIV care, interpersonal violence, trauma, mental health, and substance use. The control arm will receive one group session (60 mins.) on self-care and well-being and access to the aforementioned website with resources. Women will complete a video-based survey and mailed hair sample self-collection at baseline, 4-, 8-, and 12-months post-randomization, to evaluate improvements in ART adherence (Aim 1), emotion regulation, and PTSD symptoms (Aim 2). Investigators will examine the mediating effect of individual (retention in HIV care, coping self-efficacy, social support, ancillary support services use) and socio-structural (stigma, medical mistrust) mechanisms of change on the efficacy of Women SHINE (Aim 3).

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Women SHINE

Study Locations (1)

California

  • The Regents of the Univ. of Calif., U.C. San Diego - La Jolla

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2022-11-15
Est. Completion 2026-09-01
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT05509959

The ClinicalTrials.gov registry entry for NCT05509959 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,175-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT05509959 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05509959 about?

NCT05509959 is a clinical study titled "Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement". A two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed ART but are non-adhere...

What is the current status of trial NCT05509959?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2022-11-15. Estimated completion is 2026-09-01.

What conditions does trial NCT05509959 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT05509959?

The interventions under investigation include: Control (BEHAVIORAL), Women SHINE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05509959?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05509959 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.